Insulet (PODD) Revenue — Quarter Ended Mar 31, 2024
Revenue declined from the preceding quarter but rose compared to the same quarter one year earlier. The company's cash position strengthened while its debt-to-capital ratio improved.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue declined from the preceding quarter but rose compared to the same quarter one year earlier. The company's cash position strengthened while its debt-to-capital ratio improved.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$441.7M
Revenue reported for this quarter.
Quarter-over-quarter
-13.4%
Change from the immediately preceding quarter.
Year-over-year
+23.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $396.5M | +32.4% |
| Sep 30, 2023 | $432.7M | +27.0% |
| Dec 31, 2023 | $509.8M | +37.9% |
| Mar 31, 2024 | $441.7M | +23.3% |
Revenue performance
The quarter's revenue decreased sequentially from the immediately preceding quarter.
Quarterly comparison
Compared to the same quarter one year earlier, revenue increased. The sequential decline occurred after a strong prior quarter.
What to watch
The sequential revenue decline may be monitored in subsequent quarters for any emerging trend.